<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Embecta Corp — News on 6ix</title>
    <link>https://6ix.com/company/embecta-corp</link>
    <description>Latest news and press releases for Embecta Corp on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Tue, 21 Apr 2026 21:00:00 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/embecta-corp" rel="self" type="application/rss+xml" />
    <image>
      <url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo683562e778dffbe2df0ef073.webp</url>
      <title>Embecta Corp</title>
      <link>https://6ix.com/company/embecta-corp</link>
    </image>
    <item>
      <title>embecta to Report Fiscal Second Quarter Financial Results</title>
      <link>https://6ix.com/company/embecta-corp/news/embecta-to-report-fiscal-second-quarter-financial-results</link>
      <guid isPermaLink="true">https://6ix.com/company/embecta-corp/news/embecta-to-report-fiscal-second-quarter-financial-results</guid>
      <pubDate>Tue, 21 Apr 2026 21:00:00 GMT</pubDate>
      <description>PARSIPPANY, N.J., April 21, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, will host a conference call to discuss its fiscal second quarter 2026 financial results, provide an operational update, and host a question and answer session, at 8:00 a.m. Eastern Time (ET) on Tuesday, May 5, 2026. Those who would like to participate may access the live webcast</description>
    </item>
    <item>
      <title>embecta Announces Definitive Agreement to Acquire Owen Mumford Holdings Limited</title>
      <link>https://6ix.com/company/embecta-corp/news/embecta-announces-definitive-agreement-to-acquire-owen-mumford-holdings-limited</link>
      <guid isPermaLink="true">https://6ix.com/company/embecta-corp/news/embecta-announces-definitive-agreement-to-acquire-owen-mumford-holdings-limited</guid>
      <pubDate>Thu, 19 Mar 2026 04:00:00 GMT</pubDate>
      <description>Acquisition will position embecta to participate in the rapidly expanding market for drug-delivery devices supporting generic and branded therapies and</description>
    </item>
    <item>
      <title>embecta names new Chairman of the Board and Lead Independent Director</title>
      <link>https://6ix.com/company/embecta-corp/news/embecta-names-chairman-board-lead-211000812</link>
      <guid isPermaLink="true">https://6ix.com/company/embecta-corp/news/embecta-names-chairman-board-lead-211000812</guid>
      <pubDate>Wed, 11 Feb 2026 21:10:00 GMT</pubDate>
      <description>PARSIPPANY, N.J., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today announced that the Board of Directors (the “Board”) of embecta has elected Devdatt “Dev” Kurdikar as Chairman of the Board and Dr. Claire Pomeroy as Lead Independent Director, effective immediately. These changes follow the previously announced retirement of LTG (Ret.) David</description>
    </item>
    <item>
      <title>Embecta Corp. Reports First Quarter Fiscal 2026 Financial Results</title>
      <link>https://6ix.com/company/embecta-corp/news/embecta-corp-reports-first-quarter-113000787</link>
      <guid isPermaLink="true">https://6ix.com/company/embecta-corp/news/embecta-corp-reports-first-quarter-113000787</guid>
      <pubDate>Thu, 05 Feb 2026 11:30:00 GMT</pubDate>
      <description>PARSIPPANY, N.J., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today reported first quarter fiscal 2026 financial results. Visit the company’s Investor Relations website at http://investors.embecta.com to view the detailed first quarter fiscal 2026 earnings press release and investor presentation. The company will host a conference call and l</description>
    </item>
    <item>
      <title>embecta Announces Quarterly Cash Dividend</title>
      <link>https://6ix.com/company/embecta-corp/news/embecta-announces-quarterly-cash-dividend-2026-02-05</link>
      <guid isPermaLink="true">https://6ix.com/company/embecta-corp/news/embecta-announces-quarterly-cash-dividend-2026-02-05</guid>
      <pubDate>Thu, 05 Feb 2026 05:00:00 GMT</pubDate>
      <description>PARSIPPANY, N.J., Feb. 05, 2026 (GLOBE NEWSWIRE) -- The Board of Directors of Embecta Corp. (“embecta”) (Nasdaq: EMBC) has declared a quarterly cash dividend</description>
    </item>
    <item>
      <title>embecta to Report Fiscal First Quarter Financial Results</title>
      <link>https://6ix.com/company/embecta-corp/news/embecta-report-fiscal-first-quarter-financial-results-2026-01-22</link>
      <guid isPermaLink="true">https://6ix.com/company/embecta-corp/news/embecta-report-fiscal-first-quarter-financial-results-2026-01-22</guid>
      <pubDate>Thu, 22 Jan 2026 05:00:00 GMT</pubDate>
      <description>PARSIPPANY, N.J., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in</description>
    </item>
    <item>
      <title>embecta to Participate at the J.P. Morgan 2026 Healthcare Conference</title>
      <link>https://6ix.com/company/embecta-corp/news/embecta-participate-jp-morgan-2026-healthcare-conference-2025-12-18</link>
      <guid isPermaLink="true">https://6ix.com/company/embecta-corp/news/embecta-participate-jp-morgan-2026-healthcare-conference-2025-12-18</guid>
      <pubDate>Thu, 18 Dec 2025 05:00:00 GMT</pubDate>
      <description>PARSIPPANY, N.J., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (Nasdaq: EMBC) today announced that management will present at the J.P. Morgan</description>
    </item>
    <item>
      <title>Embecta Corp. Reports Fiscal 2025 Fourth Quarter and Full Year Financial Results; Provides Initial Fiscal Year 2026 Financial Guidance</title>
      <link>https://6ix.com/company/embecta-corp/news/embecta-corp-reports-fiscal-2025-fourth-quarter-and-full-year-financial-results</link>
      <guid isPermaLink="true">https://6ix.com/company/embecta-corp/news/embecta-corp-reports-fiscal-2025-fourth-quarter-and-full-year-financial-results</guid>
      <pubDate>Tue, 25 Nov 2025 05:00:00 GMT</pubDate>
      <description>PARSIPPANY, N.J., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the &quot;Company&quot;) (Nasdaq: EMBC), a global diabetes care company, today reported</description>
    </item>
    <item>
      <title>embecta announces changes to Board of Directors</title>
      <link>https://6ix.com/company/embecta-corp/news/embecta-announces-changes-board-directors-2025-11-17</link>
      <guid isPermaLink="true">https://6ix.com/company/embecta-corp/news/embecta-announces-changes-board-directors-2025-11-17</guid>
      <pubDate>Mon, 17 Nov 2025 05:00:00 GMT</pubDate>
      <description>PARSIPPANY, N.J., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in</description>
    </item>
    <item>
      <title>embecta Announces Major New Commitment to Direct Relief on World Diabetes Day</title>
      <link>https://6ix.com/company/embecta-corp/news/embecta-announces-major-new-commitment-direct-relief-world-diabetes-day-2025-11-14</link>
      <guid isPermaLink="true">https://6ix.com/company/embecta-corp/news/embecta-announces-major-new-commitment-direct-relief-world-diabetes-day-2025-11-14</guid>
      <pubDate>Fri, 14 Nov 2025 05:00:00 GMT</pubDate>
      <description>Expanded Partnership Will Increase Access to Diabetes Care for Communities Across the U.S. and Globally PARSIPPANY, N.J., Nov. 14, 2025 (GLOBE NEWSWIRE) -- On</description>
    </item>
    <item>
      <title>embecta to Report Fiscal Fourth Quarter and Full Year 2025 Financial Results</title>
      <link>https://6ix.com/company/embecta-corp/news/embecta-report-fiscal-fourth-quarter-and-full-year-2025-financial-results-2025-11-11</link>
      <guid isPermaLink="true">https://6ix.com/company/embecta-corp/news/embecta-report-fiscal-fourth-quarter-and-full-year-2025-financial-results-2025-11-11</guid>
      <pubDate>Tue, 11 Nov 2025 05:00:00 GMT</pubDate>
      <description>PARSIPPANY, N.J., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in</description>
    </item>
    <item>
      <title>embecta to Participate in Investor Events</title>
      <link>https://6ix.com/company/embecta-corp/news/embecta-participate-investor-events-2025-08-26</link>
      <guid isPermaLink="true">https://6ix.com/company/embecta-corp/news/embecta-participate-investor-events-2025-08-26</guid>
      <pubDate>Tue, 26 Aug 2025 04:00:00 GMT</pubDate>
      <description>PARSIPPANY, N.J., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (&quot;embecta&quot;) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in</description>
    </item>
    <item>
      <title>Embecta Corp. Reports Third Quarter Fiscal 2025 Financial Results</title>
      <link>https://6ix.com/company/embecta-corp/news/embecta-corp-reports-third-quarter-fiscal-2025-financial-results-2025-08-08</link>
      <guid isPermaLink="true">https://6ix.com/company/embecta-corp/news/embecta-corp-reports-third-quarter-fiscal-2025-financial-results-2025-08-08</guid>
      <pubDate>Fri, 08 Aug 2025 04:00:00 GMT</pubDate>
      <description>PARSIPPANY, N.J., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the &quot;Company&quot;) (Nasdaq: EMBC), a global diabetes care company, today reported</description>
    </item>
    <item>
      <title>embecta to Report Fiscal Third Quarter 2025 Financial Results</title>
      <link>https://6ix.com/company/embecta-corp/news/embecta-report-fiscal-third-quarter-2025-financial-results-2025-07-24</link>
      <guid isPermaLink="true">https://6ix.com/company/embecta-corp/news/embecta-report-fiscal-third-quarter-2025-financial-results-2025-07-24</guid>
      <pubDate>Thu, 24 Jul 2025 04:00:00 GMT</pubDate>
      <description>PARSIPPANY, N.J., July 24, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in</description>
    </item>
    <item>
      <title>embecta to Showcase Phased Approach for Value Creation and Present Long Range Financial Plan at 2025 Analyst and Investor Day</title>
      <link>https://6ix.com/company/embecta-corp/news/embecta-showcase-phased-approach-value-creation-and-present-long-range-financial-plan</link>
      <guid isPermaLink="true">https://6ix.com/company/embecta-corp/news/embecta-showcase-phased-approach-value-creation-and-present-long-range-financial-plan</guid>
      <pubDate>Thu, 22 May 2025 04:00:00 GMT</pubDate>
      <description>PARSIPPANY, N.J., May 22, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (&quot;embecta&quot;; &quot;The Company&quot;) (Nasdaq: EMBC), a global diabetes care company with a 100-year</description>
    </item>
    <item>
      <title>Embecta Corp. Reports Second Quarter Fiscal 2025 Financial Results</title>
      <link>https://6ix.com/company/embecta-corp/news/embecta-corp-reports-second-quarter-fiscal-2025-financial-results-2025-05-09</link>
      <guid isPermaLink="true">https://6ix.com/company/embecta-corp/news/embecta-corp-reports-second-quarter-fiscal-2025-financial-results-2025-05-09</guid>
      <pubDate>Fri, 09 May 2025 04:00:00 GMT</pubDate>
      <description>PARSIPPANY, N.J., May 09, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the &quot;Company&quot;) (Nasdaq: EMBC), a global diabetes care company, today reported</description>
    </item>
    <item>
      <title>Embecta to host Analyst and Investor Day on May 22, 2025</title>
      <link>https://6ix.com/company/embecta-corp/news/embecta-host-analyst-and-investor-day-may-22-2025-2025-04-28</link>
      <guid isPermaLink="true">https://6ix.com/company/embecta-corp/news/embecta-host-analyst-and-investor-day-may-22-2025-2025-04-28</guid>
      <pubDate>Mon, 28 Apr 2025 04:00:00 GMT</pubDate>
      <description>PARSIPPANY, N.J., April 28, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (&quot;embecta&quot;) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in</description>
    </item>
    <item>
      <title>embecta to Report Fiscal Second Quarter 2025 Financial Results</title>
      <link>https://6ix.com/company/embecta-corp/news/embecta-report-fiscal-second-quarter-2025-financial-results-2025-04-21</link>
      <guid isPermaLink="true">https://6ix.com/company/embecta-corp/news/embecta-report-fiscal-second-quarter-2025-financial-results-2025-04-21</guid>
      <pubDate>Mon, 21 Apr 2025 04:00:00 GMT</pubDate>
      <description>PARSIPPANY, N.J., April 21, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in</description>
    </item>
    <item>
      <title>embecta to Participate at the J.P. Morgan Global Leveraged Finance Conference</title>
      <link>https://6ix.com/company/embecta-corp/news/embecta-participate-jp-morgan-global-leveraged-finance-conference-2025-02-18</link>
      <guid isPermaLink="true">https://6ix.com/company/embecta-corp/news/embecta-participate-jp-morgan-global-leveraged-finance-conference-2025-02-18</guid>
      <pubDate>Tue, 18 Feb 2025 05:00:00 GMT</pubDate>
      <description>PARSIPPANY, N.J., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (Nasdaq: EMBC) today announced that Jake Elguicze, embecta’s Chief Financial</description>
    </item>
    <item>
      <title>Embecta Corp. Reports First Quarter Fiscal 2025 Financial Results</title>
      <link>https://6ix.com/company/embecta-corp/news/embecta-corp-reports-first-quarter-fiscal-2025-financial-results-2025-02-06</link>
      <guid isPermaLink="true">https://6ix.com/company/embecta-corp/news/embecta-corp-reports-first-quarter-fiscal-2025-financial-results-2025-02-06</guid>
      <pubDate>Thu, 06 Feb 2025 05:00:00 GMT</pubDate>
      <description>PARSIPPANY, N.J., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the &quot;Company&quot;) (Nasdaq: EMBC), a global diabetes care company, today reported</description>
    </item>
  </channel>
</rss>